Genmab — Januar 2018
-
AXL kan blive en rigtig gamechanger. Genmab ejer 100%, SGEN skal have single digit royalties, som kan udvikle sig til double digit.
-
Hvad betyder en årlig merudgift på 500 mill. andet end at virksomheden straffes med en 12 mia kroners nedgang selvom de kan performe en ny blockbuster der får mærsk kurs inden split til at ligne lommepenge. Hvis det lykkedes vil NOVO ligne en bolsjebutik sammenlignet med Genmab.
-
according to this Genmab the only one -known- in the clinic with AXL target
http://worldadc-usa.com/wp-content/uploads/sites/99/2017/09/Heather-Donaghy.pdf -
-
strange, it works for me, can you try copy paste http://worldadc-usa.com/wp-content/uploads/sites/99/2017/09/Heather-Donaghy followed by .pdf
-
-
Multiple Myeloma Patients Remain On Treatment Far Less than in Clinical Trials, Study Finds https://myelomaresearchnews.com/2018/01/12/multiple-myeloma-patients-remain-on-treatment-less-than-clinical-trials-study-finds/?utm_source=Myeloma+List&utm_campaign=2a97d50a48-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_14fcd0022a-2a97d50a48-72491777
-
-
Det er godt nok nogen sløv volume der har været de sidste dage. Man kunne jo håbe på at AQR er færdige med at holde udsalg.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind